论文部分内容阅读
目的评价早期行内镜逆行胰胆管造影(ERCP)及介入治疗对急性胆源性胰腺炎患者的安全性和临床疗效。方法将96例急性胆源性胰腺炎住院患者分为A、B两组,A组行ERCP检查和治疗,B组行内科保守治疗,分别观察其疗效和并发症,评价急性胆源性胰腺炎患者内镜治疗的安全性和疗效。结果A组患者治愈率98%,无严重并发症发生,未见因ERCP检查和治疗而使病情加重者,其腹痛缓解时间、住院天数、血淀粉酶恢复时间明显短于B组。结论早期内镜介入治疗急性胆源性胰腺炎具有微创、安全、有效、快速解除胆道急性梗阻及防止胆汁胰管反流的特点,可使急性胆源性胰腺炎患者得到快速及时的诊治,防止病情进一步发展。
Objective To evaluate the safety and clinical efficacy of early endoscopic retrograde cholangiopancreatography (ERCP) and interventional therapy in patients with acute gallstone pancreatitis. Methods A total of 96 hospitalized patients with acute gallstone pancreatitis were divided into two groups: group A and group B. ERCP was performed in group A, and conservative treatment was performed in group B. The curative effect and complication were observed respectively. Acute gallstone pancreatitis Endoscopic treatment of patients with safety and efficacy. Results The cure rate of group A was 98%. No serious complication occurred. There was no exacerbation due to ERCP examination and treatment. The pain relief time, hospitalization days and blood amylase recovery time in group A were significantly shorter than those in group B. Conclusion Early endoscopic interventional treatment of acute gallstone pancreatitis has the characteristics of minimally invasive, safe, effective and rapid relief of biliary obstruction and prevention of bile duct reflux, which can make the diagnosis and treatment of acute biliary pancreatitis quick and timely. Prevent the further development of the disease.